Randomized trial of enteric-coated mycophenolate sodium versus mycophenolate mofetil in multi-system autoimmune disease

BACKGROUND: The use of mycophenolate mofetil (MMF) in autoimmune disease is often limited by adverse effects. In this single-centre, open label, parallel design study, we investigated whether enteric-coated mycophenolate sodium (MS) is better tolerated and therefore more efficacious than MMF in prim...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Kidney J
Päätekijät: Jones, Rachel B., Walsh, Michael, Chaudhry, Afzal N., Smith, Kenneth G.C., Jayne, David R.W.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2014
Aiheet:
Original Contributions
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4389135/
https://ncbi.nlm.nih.gov/pubmed/25859373
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfu096
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia